Cargando…

Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion

Selective kappa opioid receptor (KOR) agonists are promising antipruritic agents and analgesics. However, clinical development of KOR agonists has been limited by side effects, including psychotomimetic effects, dysphoria, and sedation, except for nalfurafine, and recently. CR845 (difelikefalin). Ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chongguang, Huang, Peng, Bland, Kathryn, Li, Mengchu, Zhang, Yan, Liu-Chen, Lee-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149264/ https://www.ncbi.nlm.nih.gov/pubmed/35652052 http://dx.doi.org/10.3389/fphar.2022.835809

Ejemplares similares

Does the kappa opioid receptor system contribute to pain aversion?
por: Cahill, Catherine M., et al.
Publicado: (2014)

The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice
por: Huang, Peng, et al.
Publicado: (2020)

Expression of protein kinase A and the kappa opioid receptor in selected brain regions and conditioned place aversion in morphine-dependent rats
por: Song, Xiuhua, et al.
Publicado: (2017)

Examining Sex Differences in Conditioned Place Preference or Aversion to Methamphetamine in Adolescent and Adult Mice
por: Cullity, Ellen R., et al.
Publicado: (2021)

Exposure to chronic mild stress prevents kappa opioid-mediated reinstatement of cocaine and nicotine place preference
por: Al-Hasani, Ream, et al.
Publicado: (2013)

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022)

Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch
por: Wang, Xin, et al.
Publicado: (2021)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
por: Sturaro, Chiara, et al.
Publicado: (2022)

Neuronal activity of the medial prefrontal cortex, nucleus accumbens, and basolateral amygdala in conditioned taste aversion and conditioned place preference induced by different doses of morphine administrations in rats
por: Ou, Chen Yin, et al.
Publicado: (2023)

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
por: Escobar, Angélica del Pilar, et al.
Publicado: (2020)

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
por: Lattanzi, Roberta, et al.
Publicado: (2018)

Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction
por: Chartoff, Elena H., et al.
Publicado: (2015)

Repeated Administration of Norbinaltorphimine Produces Cumulative Kappa Opioid Receptor Inactivation
por: Chavkin, Charles, et al.
Publicado: (2019)

The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
por: Dalefield, Martin L., et al.
Publicado: (2022)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
por: Mores, Kendall L., et al.
Publicado: (2019)

Sex Differences in the Effects of a Kappa Opioid Receptor Antagonist in the Forced Swim Test
por: Laman-Maharg, Abigail, et al.
Publicado: (2018)

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents
por: Kivell, Bronwyn M., et al.
Publicado: (2018)

Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity
por: Greedy, Benjamin M., et al.
Publicado: (2013)

Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
por: Leconte, Claire, et al.
Publicado: (2022)

Editorial: Kappa opioid receptors revealed: Disentangling the pharmacology to open up new therapeutic strategies
por: Walwyn, Wendy Margaret, et al.
Publicado: (2022)

Flood-conditioned place aversion as a novel non-pharmacological aversive learning procedure in mice
por: Goltseker, Koral, et al.
Publicado: (2018)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Soyka, Michael
Publicado: (2021)

A morphine reward generalization mouse model based on conditioned place preference and aversion
por: Hou, Xue‐Fei, et al.
Publicado: (2023)

Assessing dairy calf response to long-distance transportation using conditioned place aversion
por: Creutzinger, Katherine C., et al.
Publicado: (2022)

Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors
por: Neubert, John K, et al.
Publicado: (2007)

Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review
por: Bailey, Adrian Joseph Michel, et al.
Publicado: (2022)

Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
por: Zebala, John A., et al.
Publicado: (2020)

Prevalence of COVID-19 outcomes in patients referred to opioid agonist treatment centers
por: Khani, Samira, et al.
Publicado: (2023)

Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons – Effects of Nerve Injury
por: Stötzner, Philip, et al.
Publicado: (2018)

nor-BNI Antagonism of Kappa Opioid Agonist-Induced Reinstatement of Ethanol-Seeking Behavior
por: Harshberger, Erin, et al.
Publicado: (2016)

Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation
por: Shokirova, Hurramhon, et al.
Publicado: (2021)

Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold
por: Reed, Brian, et al.
Publicado: (2022)

Quantitative proteomic analysis reveals the effects of mu opioid agonists on HT22 cells
por: Zhang, Xutong, et al.
Publicado: (2023)

Comparative Cardio-Renal Outcomes of Type 2 Diabetes Patients Administered Glucagon-Like Peptide-1 Receptor Agonists: A Network Meta-Analysis
por: Zhuo, Chuanjun, et al.
Publicado: (2021)

Role of IKK/NF-κB Signaling in Extinction of Conditioned Place Aversion Memory in Rats
por: Yang, Cheng-Hao, et al.
Publicado: (2012)

Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain
por: Yakhnitsa, Vadim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ft6gfa4163u82g8ut06t55oqu